ID

42960

Descripción

see http://clinicaltrials.gov/ct2/show/study/NCT00048295 ISIS 2302 is an antisense oligonucleotide drug that reduces the production of a specific protein called intercellular adhesion molecule (ICAM-1), a substance that plays a significant role in the increase of inflammation. People with Crohn’s disease have been shown to over-produce ICAM-1 in their gut tissues. Alicaforsen works by blocking ICAM-1 messenger RNA, the “instruction” molecule that is required for the production of ICAM-1 protein. This trial will examine effects of alicaforsen delivered by 2-hour intravenous infusion over a four-week period, compared to a placebo. Patients may remain on stable background 5-ASA, antibiotic, or immunosuppressive drugs, and prednisone (or equivalent) at </= 30 mg per day.

Link

http://clinicaltrials.gov/ct2/show/study/NCT00048295

Palabras clave

  1. 14/11/11 14/11/11 -
  2. 14/11/11 14/11/11 -
  3. 22/3/14 22/3/14 - Martin Dugas
  4. 17/9/21 17/9/21 -
Subido en

17 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility NCT00048295 Crohns Disease

Eligibility NCT00048295

  1. StudyEvent: Eligibility
    1. Eligibility NCT00048295
Inclusion
Descripción

Inclusion

Age at least 12 years
Descripción

Age

Tipo de datos

integer

Unidades de medida
  • [years]
Alias
UMLS CUI-1
C0001779
[years]
Weight at least 36 kg
Descripción

Weight

Tipo de datos

boolean

Alias
UMLS CUI-1
C0005910
CDAI score of 220 - 400
Descripción

CDAI score

Tipo de datos

boolean

Alias
UMLS CUI-1
C0451071
Documentation of Crohns disease activity by endoscopy, biopsy or imaging in the last 2 years
Descripción

Active Crohns disease

Tipo de datos

boolean

Alias
UMLS CUI-1
C0010346
No TNF-alpha inhibitor treatment for three months prior to first study drug infusion
Descripción

No TNF-alpha inhibitor

Tipo de datos

boolean

Alias
UMLS CUI-1
C1518422
UMLS CUI-2
C1456820
UMLS CUI-3
C0021469
Exclusion
Descripción

Exclusion

Known severe, fixed, symptomatic stenosis of the small or large intestine with significant dilation
Descripción

Severe intestinal stenosis

Tipo de datos

boolean

Alias
UMLS CUI-1
C0521587
Extensive external fistulization (> 3 external fistulae which are expressible with gentle compression); colostomy or ileostomy
Descripción

External fistulization

Tipo de datos

boolean

Alias
UMLS CUI-1
C0016169
Active infection, including infectious colitis, or infection with HIV, Hepatitis B or Hepatitis C
Descripción

Infection

Tipo de datos

boolean

Alias
UMLS CUI-1
C0009450
Malignancy within 3 years or poorly controlled medical illness
Descripción

Malignancy

Tipo de datos

boolean

Alias
UMLS CUI-1
C0006826
Requires intravenous heparin therapy or with a history of a bleeding problem
Descripción

Bleeding problem

Tipo de datos

boolean

Alias
UMLS CUI-1
C1458140

Similar models

Eligibility NCT00048295

  1. StudyEvent: Eligibility
    1. Eligibility NCT00048295
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion
Age
Item
Age at least 12 years
integer
C0001779 (UMLS CUI-1)
Weight
Item
Weight at least 36 kg
boolean
C0005910 (UMLS CUI-1)
CDAI score
Item
CDAI score of 220 - 400
boolean
C0451071 (UMLS CUI-1)
Active Crohns disease
Item
Documentation of Crohns disease activity by endoscopy, biopsy or imaging in the last 2 years
boolean
C0010346 (UMLS CUI-1)
No TNF-alpha inhibitor
Item
No TNF-alpha inhibitor treatment for three months prior to first study drug infusion
boolean
C1518422 (UMLS CUI-1)
C1456820 (UMLS CUI-2)
C0021469 (UMLS CUI-3)
Item Group
Exclusion
Severe intestinal stenosis
Item
Known severe, fixed, symptomatic stenosis of the small or large intestine with significant dilation
boolean
C0521587 (UMLS CUI-1)
External fistulization
Item
Extensive external fistulization (> 3 external fistulae which are expressible with gentle compression); colostomy or ileostomy
boolean
C0016169 (UMLS CUI-1)
Infection
Item
Active infection, including infectious colitis, or infection with HIV, Hepatitis B or Hepatitis C
boolean
C0009450 (UMLS CUI-1)
Malignancy
Item
Malignancy within 3 years or poorly controlled medical illness
boolean
C0006826 (UMLS CUI-1)
Bleeding problem
Item
Requires intravenous heparin therapy or with a history of a bleeding problem
boolean
C1458140 (UMLS CUI-1)

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial